Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer [20]: a low proliferation rate with a Ki67 rate lower than 14% and a high proliferation rate with a Ki67 rate higher than 14%. This evidence concerns the gene MKI67 and breast carcinoma.